Published April 30, 2019 | Version v1
Journal article

Expression of Lamin A/C in early-stage breast cancer and its prognostic value

  • 1. The University of Nottingham, Division of Breast Surgery (United Kingdom)
  • 2. The University of Nottingham, Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital (United Kingdom)
  • 3. Biotechnology Research Centre, Genetic Engineering Department (Libya)

Description

Purpose

Lamins A/C, a major component of the nuclear lamina, play key roles in maintaining nuclear integrity, regulation of gene expression, cell proliferation and apoptosis. Reduced lamin A/C expression in cancer has been reported to be a sign of poor prognosis. However, its clinical significance in breast cancer remains to be defined. This study aimed to evaluate expression and prognostic significance of lamin A/C in early-stage breast cancer.

Methods

Using immunohistochemical staining of tissue microarrays, expression of lamin A/C was evaluated in a large well-characterised series of early-stage operable breast cancer (n = 938) obtained from Nottingham Primary Breast Carcinoma Series. Association of lamin A/C expression with clinicopathological parameters and outcome was evaluated.

Results

Positive expression rate of lamin A/C in breast cancer was 42.2% (n = 398). Reduced/loss of expression of lamin A/C was significantly associated with high histological grade (p < 0.001), larger tumour size (p = 0.004), poor Nottingham Prognostic Index score (p < 0.001), lymphovascular invasion (p = 0.014) and development of distant metastasis (p = 0.027). Survival analysis showed that reduced/loss of expression of lamin A/C was significantly associated with shorter breast cancer-specific survival (p = 0.008).

Conclusion

This study suggests lamin A/C plays a role in breast cancer and loss of its expression is associated with variables of poor prognosis and shorter outcome.

Additional details

Identifiers

Publishing Information

Journal Title
Breast Cancer Research and Treatment
Journal Volume
174
Journal Issue
3
Journal Page Range
p. 661-668
ISSN
0167-6806
CODEN
BCTRD6

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51091053
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
APOPTOSIS; CARCINOMAS; CELL PROLIFERATION; GENES; MAMMARY GLANDS; METASTASES; REGULATIONS
Descriptors DEC
BODY; DISEASES; GLANDS; LAWS; NEOPLASMS; ORGANS

Optional Information

Copyright
Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature